Literature DB >> 10210909

Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases.

M Vercelletto1, M Ronin, M Huvet, C Magne, J R Feve.   

Abstract

Between 1993 and 1995, we observed five sporadic cases of frontotemporal dementia (FTD) which in all cases preceded the appearance of typical amyotrophic lateral sclerosis (ALS). The FTD rapidly became severe (within 12-18 months) and the delay between the presumed onset of mental change and ALS was short (12-26 months). The frontal dysfunction was characteristic (disinhibited, jocular, impatient, gluttonous, stereotypical gestures). The language impairment (less talkative, persistent errors, fantastic and semantic paraphasia, neologistic errors, echolalia) was constant. Single photon emission computed tomography (SPECT) with 99 Tcm HMPAO (hexamethyl propylamine oxime) was done at the same time as neuropsychological testing in four cases and showed serious diffuse bifrontal defect, sometimes with less serious internal temporal hypofixation. All patients died with bulbar ALS complications. The total course can last from 14-48 months. Most of the reported cases suggested a relationship between dementia-ALS and frontal dysfunction. The mechanism underlying dementia-ALS remains to be solved. Our five cases resemble those reported by Mitsuyama (1993), who suggested that dementia-ALS has the same clinicopathological entity. Copyright 1999 Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  1999        PMID: 10210909     DOI: 10.1046/j.1468-1331.1999.630295.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.

Authors:  Eduardo Gascon; Fen-Biao Gao
Journal:  J Neurogenet       Date:  2014-02-10       Impact factor: 1.250

2.  Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients.

Authors:  Herbert Schreiber; Tanja Gaigalat; Ursula Wiedemuth-Catrinescu; Michael Graf; Ingo Uttner; Rainer Muche; Albert Christian Ludolph
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

Review 3.  Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.

Authors:  Fen-Biao Gao; Sandra Almeida; Rodrigo Lopez-Gonzalez
Journal:  EMBO J       Date:  2017-09-15       Impact factor: 14.012

Review 4.  Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research.

Authors:  Francesca Trojsi; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  Neural Plast       Date:  2012-06-10       Impact factor: 3.599

5.  Region-specific changes in the immunoreactivity of Atg9A in the central nervous system of SOD1(G93A) transgenic mice.

Authors:  Jae Chul Lee; Soo Young Choe; Choong Ik Cha
Journal:  Anat Cell Biol       Date:  2014-06-20

6.  Examining the language and behavioural profile in FTD and ALS-FTD.

Authors:  Jennifer A Saxon; Jennifer C Thompson; Matthew Jones; Jennifer M Harris; Anna Mt Richardson; Tobias Langheinrich; David Neary; David Ma Mann; Julie S Snowden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-08       Impact factor: 10.154

7.  ALS and Frontotemporal Dysfunction: A Review.

Authors:  Eugene Y Achi; Stacy A Rudnicki
Journal:  Neurol Res Int       Date:  2012-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.